1. BL‐8040 CXCR4 antagonist is safe and demonstrates antileukemic activity in combination with cytarabine for the treatment of relapsed/refractory acute myelogenous leukemia: An open‐label safety and efficacy phase 2a study. Issue 8 (3rd December 2020) Authors: Borthakur, Gautam; Ofran, Yishai; Tallman, Martin S.; Foran, James; Uy, Geoffrey L.; DiPersio, John F.; Showel, Margaret M.; Shimoni, Avichai; Nagler, Arnon; Rowe, Jacob M.; Altman, Jessica K.; Abraham, Michal; Peled, Amnon; Shaw, Stephen; Bohana‐Kashtan, Osnat; Sorani, Ella; Pereg, Yaron; Foley‐... Journal: Cancer Issue: Volume 127:Issue 8(2021) Page Start: 1246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. In the Hunt for Therapeutic Targets. Issue 1 (January 2015) Authors: Weiss, Ido D.; Ella, Ezra; Dominsky, Omri; Smith, Yoav; Abraham, Michal; Wald, Hanna; Shlomai, Zippora; Zamir, Gideon; Feigelson, Sara W.; Shezen, Elias; Bar-Shai, Amir; Alon, Ronen; Izhar, Uzi; Peled, Amnon; Shapira, Oz M.; Wald, Ori Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. In the Hunt for Therapeutic Targets: Mimicking the Growth, Metastasis, and Stromal Associations of Early-Stage Lung Cancer Using a Novel Orthotopic Animal Model. Issue 1 (January 2015) Authors: Weiss, Ido D.; Ella, Ezra; Dominsky, Omri; Smith, Yoav; Abraham, Michal; Wald, Hanna; Shlomai, Zippora; Zamir, Gideon; Feigelson, Sara W.; Shezen, Elias; Bar-Shai, Amir; Alon, Ronen; Izhar, Uzi; Peled, Amnon; Shapira, Oz M.; Wald, Ori Journal: Journal of thoracic oncology Issue: Volume 10:Issue 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Inflammation‐induced hepatocellular carcinoma is dependent on CCR5 in mice. Issue 3 (12th July 2013) Authors: Barashi, Neta; Weiss, Ido D.; Wald, Ori; Wald, Hanna; Beider, Katia; Abraham, Michal; Klein, Shiri; Goldenberg, Daniel; Axelrod, Jonathan; Pikarsky, Eli; Abramovitch, Rinat; Zeira, Evelyne; Galun, Eithan; Peled, Amnon Journal: Hepatology Issue: Volume 58:Issue 3(2013:Sep.) Page Start: 1021 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Promiscuous Chemokine Antagonist (BKT130) Suppresses Laser-Induced Choroidal Neovascularization by Inhibition of Monocyte Recruitment. (5th August 2019) Authors: Hagbi-Levi, Shira; Abraham, Michal; Tiosano, Liran; Rinsky, Batya; Grunin, Michelle; Eizenberg, Orly; Peled, Amnon; Chowers, Itay Other Names: Medbury Heather Guest Editor. Journal: Journal of immunology research Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Role of CXCL12 and CXCR4 in the pathogenesis of hematological malignancies. (September 2018) Authors: Peled, Amnon; Klein, Shiri; Beider, Katia; Burger, Jan A.; Abraham, Michal Journal: Cytokine Issue: Volume 109(2018) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Sequential administration of the high affinity CXCR4 antagonist BKT140 promotes megakaryopoiesis and platelet production. (1st August 2013) Authors: Abraham, Michal; Weiss, Ido D.; Wald, Hanna; Wald, Ori; Nagler, Arnon; Beider, Katia; Eizenberg, Orly; Peled, Amnon Journal: British journal of haematology Issue: Volume 163:Number 2(2013:Oct.) Page Start: 248 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗